Clinical trials
Withdrawn Scleroderma, Systemic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Echosense Ltd. | 2 |
| Beijing Boren Hospital | 1 |
| Biogen | 1 |
| Calibr, a division of Scripps Research | 1 |
| Central Hospital, Nancy, France | 1 |
| Duke University | 1 |
| Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium | 1 |
| Nanjing Legend Biotech Co. | 1 |
| Paul Farand | 1 |
| Taipei Veterans General Hospital, Taiwan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Systemic | 14 |
| Lupus Erythematosus, Systemic | 4 |
| Hypertension, Pulmonary | 3 |
| Myositis | 3 |
| Scleroderma, Diffuse | 2 |
| Sjogren's Syndrome | 2 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
| Arthritis, Rheumatoid | 1 |
| Autoimmune Diseases | 1 |
Trials
Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.